High dose rate endobronchial brachytherapy effectively palliates symptoms due to inoperable lung cancer.

Celebioglu, EMİNE; Gurkan, OU; Erdogan, S; Savas, I; Kose, K; Kurtman, C; Gonullu, U

doi:10.1093/jjco/hyf102

High dose rate endobronchial brachytherapy effectively palliates symptoms due to inoperable lung cancer.

Celebioglu B., Gurkan O., Erdogan S., Savas I., Kose K., Kurtman C., ...Daha Fazla

Japanese journal of clinical oncology, cilt.32, sa.11, ss.443-8, 2002 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 32 Sayı: 11
Basım Tarihi: 2002
Doi Numarası: 10.1093/jjco/hyf102
Dergi Adı: Japanese journal of clinical oncology
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.443-8
Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
Kocaeli Üniversitesi Adresli: Evet

Özet

Background: Intraluminal brachytherapy has become an established treatment for major airway occlusion by relapsed or persistent inoperable endobronchial tumors. The aim of this study was to compare the palliation improvement pre- and post-radiotherapy.